Alpine Immune Sciences is now part of Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. For more information about Vertex, please visit us at https://www.vrtx.com/. Follow Vertex on LinkedIn for future updates at https://www.linkedin.com/company/vertex-pharmaceuticals/.
External link for Alpine Immune Sciences, Inc.
188 E Blaine St
200
Seattle, Washington 98102, US
Alpine Immune Sciences, Inc. reposted this
Today we announced that we have entered into a definitive agreement under which Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will acquire Alpine. For key information and cautionary statements, read our press release: https://bit.ly/49rcqrq
Today we announced that we have entered into a definitive agreement under which Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will acquire Alpine. For key information and cautionary statements, read our press release: https://bit.ly/49rcqrq
#ALPNews: Today we announced that we will participate in a fireside chat at the upcoming H.C. Wainwright 2nd Annual Autoimmune and Inflammatory Disease Virtual Conference, March 28, 2024, and host investor meetings. #healthcareconference #biotech #investors For more information, visit: https://bit.ly/4al3Z1Q
#ALPNews: Yesterday, we released our fourth quarter and full year 2023 financial results and conducted a webcast. To learn more, read our press release: https://bit.ly/49ZiTuH or listen to our webcast at: https://bit.ly/43nvANy $ALPN
On this World Kidney Day Alpine is proud to support the global initiative of "Kidney Health for All” while advancing equitable access to optimal medical care. At Alpine, we are advancing therapies that can potentially improve the lives of patients with autoimmune kidney diseases. #healthykidneysforall
#ALPNews: We will release our fourth quarter and full year 2023 financial results on Monday, March 18, and conduct a webcast the same day at 4:30 p.m. ET / 1:30 p.m. PT $ALPN For more: https://bit.ly/4c8cUoZ
March is Autoimmune Awareness Month. At Alpine, we are raising awareness and developing therapies to create hope and to potentially improve the lives of millions of people living with autoimmune disease. To learn more: https://bit.ly/3Il4oFf #AutoimmuneAwarenessMonth
This #RareDiseaseDay, we want to take a moment to raise awareness of the 300 million people worldwide living with a rare disease. We remain committed to developing innovative treatments for people living with autoimmune and inflammatory diseases so that they may live longer, fuller lives.
#ALPNews: This week we announced that we'll participate in the upcoming TD Cowen Inc. 44th Annual Healthcare Conference, March 4-6 in Boston and the Leerink Partners Biopharma Conference, March 11-13, in Miami. For more information, visit: https://bit.ly/48yI6dS
In honor of #PresidentsDay, we want to take a moment to honor our past leaders and reflect on America’s foundational values.